Evolution Wealth Advisors, LLC Cardiff Oncology, Inc. Transaction History

Evolution Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$5.18 - $7.24 $2,222 - $3,105	-429 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$5.01 - $7.58 $1,908 - $2,887	-381 Reduced 47.04%	429 $3,000
Q1 2021 Apr 20, 2021	BUY	$9.1 - $19.57 $2,702 - $5,812	297 Added 57.89%	810 $8,000
Q4 2020 Feb 02, 2021	BUY	$12.02 - $24.71 $6,166 - $12,676	513 New	513 $9,000

12.3M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $120M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.